Product Information
FT MUCUS RELIEF ER 600 MG TAB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.2840 per EA under NDC 70677105201. Its NADAC has been published 161 times since Sep 6, 2023.
FDA first approved this application on Jul 11, 2018.
Strength
600 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677105201
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA207342FDA Approved
7/11/2018
On Market Since
3/31/2023
Pharmacological Classes
Price Statistics
The NADAC for FT MUCUS RELIEF ER 600 MG TAB has been published 161 times since Sep 6, 2023, and over the history we have for it it has declined 5.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2840 per EA |
|---|---|
| All-time high | $0.3993 (Dec 11, 2024) |
| All-time low | $0.2812 (Oct 18, 2023) |
| 52-week high | $0.3211 |
| 52-week low | $0.2840 |
| Median price | $0.3201 |
| Average price | $0.3211 |
| Largest weekly change | +24.7% (Nov 20, 2024) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT MUCUS RELIEF ER 600 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FT MUCUS RELIEF ER 600 MG TAB, manufactured by Strategic Sourcing Services LLC, is $0.2840 per EA (NDC 70677105201), effective Sep 30, 2026.
How has the price of FT MUCUS RELIEF ER 600 MG TAB changed over time?
Over the history we have for it, the NADAC for FT MUCUS RELIEF ER 600 MG TAB has declined 5.8%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for FT MUCUS RELIEF ER 600 MG TAB?
Since Sep 6, 2023, the NADAC for FT MUCUS RELIEF ER 600 MG TAB has ranged from a low of $0.2812 (Oct 18, 2023) to a high of $0.3993 (Dec 11, 2024), with a median of $0.3201 per EA.
Are there cheaper alternatives to FT MUCUS RELIEF ER 600 MG TAB?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT MUCUS RELIEF ER 600 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FT MUCUS RELIEF ER 600 MG TAB?
FT MUCUS RELIEF ER 600 MG TAB (NDC 70677105201) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.